nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Melatonin—MPO—atherosclerosis	0.00324	0.571	CrCbGaD
Zolmitriptan—Melatonin—ESR1—atherosclerosis	0.00243	0.429	CrCbGaD
Zolmitriptan—Chills—Simvastatin—atherosclerosis	0.0017	0.00242	CcSEcCtD
Zolmitriptan—Muscle spasms—Lovastatin—atherosclerosis	0.0017	0.00242	CcSEcCtD
Zolmitriptan—Infection—Rosuvastatin—atherosclerosis	0.00169	0.00241	CcSEcCtD
Zolmitriptan—Back pain—Ezetimibe—atherosclerosis	0.00167	0.00239	CcSEcCtD
Zolmitriptan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00167	0.00237	CcSEcCtD
Zolmitriptan—Muscle spasms—Ezetimibe—atherosclerosis	0.00166	0.00237	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00166	0.00237	CcSEcCtD
Zolmitriptan—Tremor—Lovastatin—atherosclerosis	0.00165	0.00236	CcSEcCtD
Zolmitriptan—Erythema—Simvastatin—atherosclerosis	0.00165	0.00235	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Lovastatin—atherosclerosis	0.00164	0.00233	CcSEcCtD
Zolmitriptan—Tinnitus—Niacin—atherosclerosis	0.00162	0.00231	CcSEcCtD
Zolmitriptan—Dysgeusia—Simvastatin—atherosclerosis	0.00162	0.0023	CcSEcCtD
Zolmitriptan—Angioedema—Lovastatin—atherosclerosis	0.00161	0.0023	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00161	0.00229	CcSEcCtD
Zolmitriptan—Tinnitus—Pravastatin—atherosclerosis	0.0016	0.00228	CcSEcCtD
Zolmitriptan—Malaise—Lovastatin—atherosclerosis	0.00159	0.00227	CcSEcCtD
Zolmitriptan—Cardiac disorder—Pravastatin—atherosclerosis	0.00159	0.00227	CcSEcCtD
Zolmitriptan—Muscle spasms—Simvastatin—atherosclerosis	0.00159	0.00226	CcSEcCtD
Zolmitriptan—Vertigo—Lovastatin—atherosclerosis	0.00158	0.00226	CcSEcCtD
Zolmitriptan—Angioedema—Ezetimibe—atherosclerosis	0.00158	0.00225	CcSEcCtD
Zolmitriptan—Angiopathy—Niacin—atherosclerosis	0.00158	0.00225	CcSEcCtD
Zolmitriptan—Leukopenia—Lovastatin—atherosclerosis	0.00158	0.00225	CcSEcCtD
Zolmitriptan—Chills—Niacin—atherosclerosis	0.00156	0.00223	CcSEcCtD
Zolmitriptan—Malaise—Ezetimibe—atherosclerosis	0.00156	0.00222	CcSEcCtD
Zolmitriptan—Arrhythmia—Niacin—atherosclerosis	0.00155	0.00222	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00155	0.00221	CcSEcCtD
Zolmitriptan—Tremor—Simvastatin—atherosclerosis	0.00155	0.0022	CcSEcCtD
Zolmitriptan—Chills—Pravastatin—atherosclerosis	0.00154	0.00219	CcSEcCtD
Zolmitriptan—Insomnia—Rosuvastatin—atherosclerosis	0.00154	0.00219	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Simvastatin—atherosclerosis	0.00153	0.00218	CcSEcCtD
Zolmitriptan—Arrhythmia—Pravastatin—atherosclerosis	0.00153	0.00218	CcSEcCtD
Zolmitriptan—Palpitations—Ezetimibe—atherosclerosis	0.00153	0.00218	CcSEcCtD
Zolmitriptan—Paraesthesia—Rosuvastatin—atherosclerosis	0.00153	0.00217	CcSEcCtD
Zolmitriptan—Erythema—Niacin—atherosclerosis	0.00151	0.00216	CcSEcCtD
Zolmitriptan—Cough—Ezetimibe—atherosclerosis	0.00151	0.00215	CcSEcCtD
Zolmitriptan—Angioedema—Simvastatin—atherosclerosis	0.00151	0.00215	CcSEcCtD
Zolmitriptan—Arthralgia—Lovastatin—atherosclerosis	0.0015	0.00214	CcSEcCtD
Zolmitriptan—Chest pain—Lovastatin—atherosclerosis	0.0015	0.00214	CcSEcCtD
Zolmitriptan—Myalgia—Lovastatin—atherosclerosis	0.0015	0.00214	CcSEcCtD
Zolmitriptan—Anxiety—Lovastatin—atherosclerosis	0.0015	0.00213	CcSEcCtD
Zolmitriptan—Dyspepsia—Rosuvastatin—atherosclerosis	0.0015	0.00213	CcSEcCtD
Zolmitriptan—Hypertension—Ezetimibe—atherosclerosis	0.00149	0.00213	CcSEcCtD
Zolmitriptan—Malaise—Simvastatin—atherosclerosis	0.00149	0.00212	CcSEcCtD
Zolmitriptan—Tension—Niacin—atherosclerosis	0.00149	0.00212	CcSEcCtD
Zolmitriptan—Discomfort—Lovastatin—atherosclerosis	0.00148	0.00212	CcSEcCtD
Zolmitriptan—Vertigo—Simvastatin—atherosclerosis	0.00148	0.00211	CcSEcCtD
Zolmitriptan—Leukopenia—Simvastatin—atherosclerosis	0.00148	0.00211	CcSEcCtD
Zolmitriptan—Arthralgia—Ezetimibe—atherosclerosis	0.00147	0.0021	CcSEcCtD
Zolmitriptan—Chest pain—Ezetimibe—atherosclerosis	0.00147	0.0021	CcSEcCtD
Zolmitriptan—Myalgia—Ezetimibe—atherosclerosis	0.00147	0.0021	CcSEcCtD
Zolmitriptan—Nervousness—Niacin—atherosclerosis	0.00147	0.0021	CcSEcCtD
Zolmitriptan—Dry mouth—Lovastatin—atherosclerosis	0.00147	0.00209	CcSEcCtD
Zolmitriptan—Tension—Pravastatin—atherosclerosis	0.00146	0.00209	CcSEcCtD
Zolmitriptan—Dysgeusia—Pravastatin—atherosclerosis	0.00146	0.00208	CcSEcCtD
Zolmitriptan—Muscle spasms—Niacin—atherosclerosis	0.00146	0.00208	CcSEcCtD
Zolmitriptan—Discomfort—Ezetimibe—atherosclerosis	0.00146	0.00207	CcSEcCtD
Zolmitriptan—Pain—Rosuvastatin—atherosclerosis	0.00145	0.00207	CcSEcCtD
Zolmitriptan—Constipation—Rosuvastatin—atherosclerosis	0.00145	0.00207	CcSEcCtD
Zolmitriptan—Confusional state—Lovastatin—atherosclerosis	0.00145	0.00207	CcSEcCtD
Zolmitriptan—Nervousness—Pravastatin—atherosclerosis	0.00145	0.00207	CcSEcCtD
Zolmitriptan—Dry mouth—Ezetimibe—atherosclerosis	0.00144	0.00205	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Lovastatin—atherosclerosis	0.00144	0.00205	CcSEcCtD
Zolmitriptan—Muscle spasms—Pravastatin—atherosclerosis	0.00143	0.00204	CcSEcCtD
Zolmitriptan—Infection—Lovastatin—atherosclerosis	0.00143	0.00204	CcSEcCtD
Zolmitriptan—Confusional state—Ezetimibe—atherosclerosis	0.00142	0.00203	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00141	0.00201	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Lovastatin—atherosclerosis	0.00141	0.00201	CcSEcCtD
Zolmitriptan—Chest pain—Simvastatin—atherosclerosis	0.0014	0.002	CcSEcCtD
Zolmitriptan—Arthralgia—Simvastatin—atherosclerosis	0.0014	0.002	CcSEcCtD
Zolmitriptan—Myalgia—Simvastatin—atherosclerosis	0.0014	0.002	CcSEcCtD
Zolmitriptan—Infection—Ezetimibe—atherosclerosis	0.0014	0.002	CcSEcCtD
Zolmitriptan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0014	0.002	CcSEcCtD
Zolmitriptan—Anxiety—Simvastatin—atherosclerosis	0.0014	0.002	CcSEcCtD
Zolmitriptan—Tremor—Pravastatin—atherosclerosis	0.0014	0.00199	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00139	0.00198	CcSEcCtD
Zolmitriptan—Discomfort—Simvastatin—atherosclerosis	0.00139	0.00198	CcSEcCtD
Zolmitriptan—Nervous system disorder—Ezetimibe—atherosclerosis	0.00138	0.00197	CcSEcCtD
Zolmitriptan—Angioedema—Niacin—atherosclerosis	0.00138	0.00197	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Pravastatin—atherosclerosis	0.00138	0.00197	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00138	0.00197	CcSEcCtD
Zolmitriptan—Anorexia—Lovastatin—atherosclerosis	0.00137	0.00196	CcSEcCtD
Zolmitriptan—Skin disorder—Ezetimibe—atherosclerosis	0.00137	0.00196	CcSEcCtD
Zolmitriptan—Angioedema—Pravastatin—atherosclerosis	0.00136	0.00194	CcSEcCtD
Zolmitriptan—Vertigo—Niacin—atherosclerosis	0.00136	0.00194	CcSEcCtD
Zolmitriptan—Syncope—Niacin—atherosclerosis	0.00136	0.00194	CcSEcCtD
Zolmitriptan—Confusional state—Simvastatin—atherosclerosis	0.00136	0.00194	CcSEcCtD
Zolmitriptan—Leukopenia—Niacin—atherosclerosis	0.00136	0.00193	CcSEcCtD
Zolmitriptan—Urticaria—Rosuvastatin—atherosclerosis	0.00135	0.00192	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Simvastatin—atherosclerosis	0.00135	0.00192	CcSEcCtD
Zolmitriptan—Oedema—Simvastatin—atherosclerosis	0.00135	0.00192	CcSEcCtD
Zolmitriptan—Malaise—Pravastatin—atherosclerosis	0.00135	0.00192	CcSEcCtD
Zolmitriptan—Abdominal pain—Rosuvastatin—atherosclerosis	0.00134	0.00191	CcSEcCtD
Zolmitriptan—Vertigo—Pravastatin—atherosclerosis	0.00134	0.00191	CcSEcCtD
Zolmitriptan—Palpitations—Niacin—atherosclerosis	0.00134	0.00191	CcSEcCtD
Zolmitriptan—Infection—Simvastatin—atherosclerosis	0.00134	0.00191	CcSEcCtD
Zolmitriptan—Leukopenia—Pravastatin—atherosclerosis	0.00134	0.0019	CcSEcCtD
Zolmitriptan—Loss of consciousness—Niacin—atherosclerosis	0.00133	0.0019	CcSEcCtD
Zolmitriptan—Cough—Niacin—atherosclerosis	0.00132	0.00188	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Simvastatin—atherosclerosis	0.00132	0.00188	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00131	0.00187	CcSEcCtD
Zolmitriptan—Insomnia—Lovastatin—atherosclerosis	0.0013	0.00186	CcSEcCtD
Zolmitriptan—Cough—Pravastatin—atherosclerosis	0.0013	0.00186	CcSEcCtD
Zolmitriptan—Paraesthesia—Lovastatin—atherosclerosis	0.00129	0.00184	CcSEcCtD
Zolmitriptan—Arthralgia—Niacin—atherosclerosis	0.00129	0.00184	CcSEcCtD
Zolmitriptan—Myalgia—Niacin—atherosclerosis	0.00129	0.00184	CcSEcCtD
Zolmitriptan—Hypertension—Pravastatin—atherosclerosis	0.00129	0.00184	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00129	0.00183	CcSEcCtD
Zolmitriptan—Anorexia—Simvastatin—atherosclerosis	0.00128	0.00183	CcSEcCtD
Zolmitriptan—Dyspnoea—Lovastatin—atherosclerosis	0.00128	0.00183	CcSEcCtD
Zolmitriptan—Insomnia—Ezetimibe—atherosclerosis	0.00128	0.00182	CcSEcCtD
Zolmitriptan—Chest pain—Pravastatin—atherosclerosis	0.00127	0.00181	CcSEcCtD
Zolmitriptan—Myalgia—Pravastatin—atherosclerosis	0.00127	0.00181	CcSEcCtD
Zolmitriptan—Arthralgia—Pravastatin—atherosclerosis	0.00127	0.00181	CcSEcCtD
Zolmitriptan—Paraesthesia—Ezetimibe—atherosclerosis	0.00127	0.00181	CcSEcCtD
Zolmitriptan—Dyspepsia—Lovastatin—atherosclerosis	0.00127	0.00181	CcSEcCtD
Zolmitriptan—Anxiety—Pravastatin—atherosclerosis	0.00127	0.0018	CcSEcCtD
Zolmitriptan—Dry mouth—Niacin—atherosclerosis	0.00126	0.0018	CcSEcCtD
Zolmitriptan—Dyspnoea—Ezetimibe—atherosclerosis	0.00126	0.00179	CcSEcCtD
Zolmitriptan—Discomfort—Pravastatin—atherosclerosis	0.00125	0.00179	CcSEcCtD
Zolmitriptan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00125	0.00178	CcSEcCtD
Zolmitriptan—Decreased appetite—Lovastatin—atherosclerosis	0.00125	0.00178	CcSEcCtD
Zolmitriptan—Dyspepsia—Ezetimibe—atherosclerosis	0.00124	0.00177	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Niacin—atherosclerosis	0.00124	0.00176	CcSEcCtD
Zolmitriptan—Oedema—Niacin—atherosclerosis	0.00124	0.00176	CcSEcCtD
Zolmitriptan—Constipation—Lovastatin—atherosclerosis	0.00123	0.00175	CcSEcCtD
Zolmitriptan—Pain—Lovastatin—atherosclerosis	0.00123	0.00175	CcSEcCtD
Zolmitriptan—Confusional state—Pravastatin—atherosclerosis	0.00123	0.00175	CcSEcCtD
Zolmitriptan—Decreased appetite—Ezetimibe—atherosclerosis	0.00123	0.00175	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00123	0.00175	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00122	0.00174	CcSEcCtD
Zolmitriptan—Asthenia—Rosuvastatin—atherosclerosis	0.00122	0.00174	CcSEcCtD
Zolmitriptan—Insomnia—Simvastatin—atherosclerosis	0.00122	0.00174	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Pravastatin—atherosclerosis	0.00122	0.00174	CcSEcCtD
Zolmitriptan—Oedema—Pravastatin—atherosclerosis	0.00122	0.00174	CcSEcCtD
Zolmitriptan—Shock—Niacin—atherosclerosis	0.00122	0.00173	CcSEcCtD
Zolmitriptan—Infection—Pravastatin—atherosclerosis	0.00121	0.00172	CcSEcCtD
Zolmitriptan—Paraesthesia—Simvastatin—atherosclerosis	0.00121	0.00172	CcSEcCtD
Zolmitriptan—Pain—Ezetimibe—atherosclerosis	0.00121	0.00172	CcSEcCtD
Zolmitriptan—Constipation—Ezetimibe—atherosclerosis	0.00121	0.00172	CcSEcCtD
Zolmitriptan—Tachycardia—Niacin—atherosclerosis	0.00121	0.00172	CcSEcCtD
Zolmitriptan—Pruritus—Rosuvastatin—atherosclerosis	0.0012	0.00171	CcSEcCtD
Zolmitriptan—Skin disorder—Niacin—atherosclerosis	0.0012	0.00171	CcSEcCtD
Zolmitriptan—Dyspnoea—Simvastatin—atherosclerosis	0.0012	0.00171	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Niacin—atherosclerosis	0.0012	0.0017	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Pravastatin—atherosclerosis	0.00119	0.0017	CcSEcCtD
Zolmitriptan—Feeling abnormal—Lovastatin—atherosclerosis	0.00119	0.00169	CcSEcCtD
Zolmitriptan—Dyspepsia—Simvastatin—atherosclerosis	0.00119	0.00169	CcSEcCtD
Zolmitriptan—Anorexia—Niacin—atherosclerosis	0.00118	0.00168	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00118	0.00168	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Pravastatin—atherosclerosis	0.00118	0.00168	CcSEcCtD
Zolmitriptan—HTR1B—artery—atherosclerosis	0.00117	0.169	CbGeAlD
Zolmitriptan—Decreased appetite—Simvastatin—atherosclerosis	0.00117	0.00167	CcSEcCtD
Zolmitriptan—Feeling abnormal—Ezetimibe—atherosclerosis	0.00116	0.00166	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00116	0.00166	CcSEcCtD
Zolmitriptan—Diarrhoea—Rosuvastatin—atherosclerosis	0.00116	0.00166	CcSEcCtD
Zolmitriptan—Anorexia—Pravastatin—atherosclerosis	0.00116	0.00165	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00115	0.00165	CcSEcCtD
Zolmitriptan—Constipation—Simvastatin—atherosclerosis	0.00115	0.00164	CcSEcCtD
Zolmitriptan—Pain—Simvastatin—atherosclerosis	0.00115	0.00164	CcSEcCtD
Zolmitriptan—Urticaria—Lovastatin—atherosclerosis	0.00114	0.00163	CcSEcCtD
Zolmitriptan—Body temperature increased—Lovastatin—atherosclerosis	0.00114	0.00162	CcSEcCtD
Zolmitriptan—Abdominal pain—Lovastatin—atherosclerosis	0.00114	0.00162	CcSEcCtD
Zolmitriptan—HTR1D—artery—atherosclerosis	0.00113	0.164	CbGeAlD
Zolmitriptan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00113	0.00161	CcSEcCtD
Zolmitriptan—Dizziness—Rosuvastatin—atherosclerosis	0.00112	0.0016	CcSEcCtD
Zolmitriptan—Urticaria—Ezetimibe—atherosclerosis	0.00112	0.0016	CcSEcCtD
Zolmitriptan—Insomnia—Niacin—atherosclerosis	0.00112	0.00159	CcSEcCtD
Zolmitriptan—Abdominal pain—Ezetimibe—atherosclerosis	0.00112	0.00159	CcSEcCtD
Zolmitriptan—Body temperature increased—Ezetimibe—atherosclerosis	0.00112	0.00159	CcSEcCtD
Zolmitriptan—Paraesthesia—Niacin—atherosclerosis	0.00111	0.00158	CcSEcCtD
Zolmitriptan—Feeling abnormal—Simvastatin—atherosclerosis	0.00111	0.00158	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00111	0.00158	CcSEcCtD
Zolmitriptan—Dyspnoea—Niacin—atherosclerosis	0.0011	0.00157	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0011	0.00157	CcSEcCtD
Zolmitriptan—Insomnia—Pravastatin—atherosclerosis	0.0011	0.00157	CcSEcCtD
Zolmitriptan—Somnolence—Niacin—atherosclerosis	0.0011	0.00157	CcSEcCtD
Zolmitriptan—Paraesthesia—Pravastatin—atherosclerosis	0.00109	0.00156	CcSEcCtD
Zolmitriptan—Dyspepsia—Niacin—atherosclerosis	0.00109	0.00155	CcSEcCtD
Zolmitriptan—Dyspnoea—Pravastatin—atherosclerosis	0.00109	0.00155	CcSEcCtD
Zolmitriptan—Decreased appetite—Niacin—atherosclerosis	0.00107	0.00153	CcSEcCtD
Zolmitriptan—Dyspepsia—Pravastatin—atherosclerosis	0.00107	0.00153	CcSEcCtD
Zolmitriptan—Rash—Rosuvastatin—atherosclerosis	0.00107	0.00153	CcSEcCtD
Zolmitriptan—Dermatitis—Rosuvastatin—atherosclerosis	0.00107	0.00153	CcSEcCtD
Zolmitriptan—Urticaria—Simvastatin—atherosclerosis	0.00107	0.00152	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Niacin—atherosclerosis	0.00107	0.00152	CcSEcCtD
Zolmitriptan—Body temperature increased—Simvastatin—atherosclerosis	0.00106	0.00152	CcSEcCtD
Zolmitriptan—Abdominal pain—Simvastatin—atherosclerosis	0.00106	0.00152	CcSEcCtD
Zolmitriptan—Headache—Rosuvastatin—atherosclerosis	0.00106	0.00152	CcSEcCtD
Zolmitriptan—Hypersensitivity—Lovastatin—atherosclerosis	0.00106	0.00151	CcSEcCtD
Zolmitriptan—Decreased appetite—Pravastatin—atherosclerosis	0.00106	0.00151	CcSEcCtD
Zolmitriptan—Pain—Niacin—atherosclerosis	0.00106	0.00151	CcSEcCtD
Zolmitriptan—Constipation—Pravastatin—atherosclerosis	0.00104	0.00148	CcSEcCtD
Zolmitriptan—Pain—Pravastatin—atherosclerosis	0.00104	0.00148	CcSEcCtD
Zolmitriptan—Hypersensitivity—Ezetimibe—atherosclerosis	0.00104	0.00148	CcSEcCtD
Zolmitriptan—Asthenia—Lovastatin—atherosclerosis	0.00103	0.00147	CcSEcCtD
Zolmitriptan—Pruritus—Lovastatin—atherosclerosis	0.00102	0.00145	CcSEcCtD
Zolmitriptan—Asthenia—Ezetimibe—atherosclerosis	0.00101	0.00144	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Niacin—atherosclerosis	0.00101	0.00144	CcSEcCtD
Zolmitriptan—Nausea—Rosuvastatin—atherosclerosis	0.00101	0.00144	CcSEcCtD
Zolmitriptan—Feeling abnormal—Pravastatin—atherosclerosis	0.001	0.00143	CcSEcCtD
Zolmitriptan—Pruritus—Ezetimibe—atherosclerosis	0.000999	0.00142	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000995	0.00142	CcSEcCtD
Zolmitriptan—Hypersensitivity—Simvastatin—atherosclerosis	0.000992	0.00141	CcSEcCtD
Zolmitriptan—Diarrhoea—Lovastatin—atherosclerosis	0.000985	0.0014	CcSEcCtD
Zolmitriptan—Urticaria—Niacin—atherosclerosis	0.000982	0.0014	CcSEcCtD
Zolmitriptan—Body temperature increased—Niacin—atherosclerosis	0.000977	0.00139	CcSEcCtD
Zolmitriptan—Abdominal pain—Niacin—atherosclerosis	0.000977	0.00139	CcSEcCtD
Zolmitriptan—Urticaria—Pravastatin—atherosclerosis	0.000967	0.00138	CcSEcCtD
Zolmitriptan—Asthenia—Simvastatin—atherosclerosis	0.000966	0.00138	CcSEcCtD
Zolmitriptan—Diarrhoea—Ezetimibe—atherosclerosis	0.000966	0.00138	CcSEcCtD
Zolmitriptan—Body temperature increased—Pravastatin—atherosclerosis	0.000962	0.00137	CcSEcCtD
Zolmitriptan—Abdominal pain—Pravastatin—atherosclerosis	0.000962	0.00137	CcSEcCtD
Zolmitriptan—Pruritus—Simvastatin—atherosclerosis	0.000953	0.00136	CcSEcCtD
Zolmitriptan—Dizziness—Lovastatin—atherosclerosis	0.000952	0.00136	CcSEcCtD
Zolmitriptan—Dizziness—Ezetimibe—atherosclerosis	0.000934	0.00133	CcSEcCtD
Zolmitriptan—Diarrhoea—Simvastatin—atherosclerosis	0.000921	0.00131	CcSEcCtD
Zolmitriptan—Vomiting—Lovastatin—atherosclerosis	0.000915	0.0013	CcSEcCtD
Zolmitriptan—HTR1B—blood vessel—atherosclerosis	0.000912	0.132	CbGeAlD
Zolmitriptan—Hypersensitivity—Niacin—atherosclerosis	0.000911	0.0013	CcSEcCtD
Zolmitriptan—Rash—Lovastatin—atherosclerosis	0.000908	0.00129	CcSEcCtD
Zolmitriptan—Dermatitis—Lovastatin—atherosclerosis	0.000907	0.00129	CcSEcCtD
Zolmitriptan—Headache—Lovastatin—atherosclerosis	0.000902	0.00129	CcSEcCtD
Zolmitriptan—Vomiting—Ezetimibe—atherosclerosis	0.000898	0.00128	CcSEcCtD
Zolmitriptan—Hypersensitivity—Pravastatin—atherosclerosis	0.000897	0.00128	CcSEcCtD
Zolmitriptan—Dizziness—Simvastatin—atherosclerosis	0.00089	0.00127	CcSEcCtD
Zolmitriptan—Rash—Ezetimibe—atherosclerosis	0.00089	0.00127	CcSEcCtD
Zolmitriptan—Dermatitis—Ezetimibe—atherosclerosis	0.000889	0.00127	CcSEcCtD
Zolmitriptan—Asthenia—Niacin—atherosclerosis	0.000887	0.00126	CcSEcCtD
Zolmitriptan—Headache—Ezetimibe—atherosclerosis	0.000884	0.00126	CcSEcCtD
Zolmitriptan—HTR1D—blood vessel—atherosclerosis	0.000883	0.127	CbGeAlD
Zolmitriptan—Pruritus—Niacin—atherosclerosis	0.000875	0.00125	CcSEcCtD
Zolmitriptan—Asthenia—Pravastatin—atherosclerosis	0.000873	0.00125	CcSEcCtD
Zolmitriptan—Pruritus—Pravastatin—atherosclerosis	0.000861	0.00123	CcSEcCtD
Zolmitriptan—Vomiting—Simvastatin—atherosclerosis	0.000856	0.00122	CcSEcCtD
Zolmitriptan—Nausea—Lovastatin—atherosclerosis	0.000855	0.00122	CcSEcCtD
Zolmitriptan—Rash—Simvastatin—atherosclerosis	0.000849	0.00121	CcSEcCtD
Zolmitriptan—Dermatitis—Simvastatin—atherosclerosis	0.000848	0.00121	CcSEcCtD
Zolmitriptan—Diarrhoea—Niacin—atherosclerosis	0.000846	0.00121	CcSEcCtD
Zolmitriptan—Headache—Simvastatin—atherosclerosis	0.000843	0.0012	CcSEcCtD
Zolmitriptan—Nausea—Ezetimibe—atherosclerosis	0.000839	0.0012	CcSEcCtD
Zolmitriptan—Diarrhoea—Pravastatin—atherosclerosis	0.000833	0.00119	CcSEcCtD
Zolmitriptan—Dizziness—Niacin—atherosclerosis	0.000818	0.00117	CcSEcCtD
Zolmitriptan—Dizziness—Pravastatin—atherosclerosis	0.000805	0.00115	CcSEcCtD
Zolmitriptan—Nausea—Simvastatin—atherosclerosis	0.0008	0.00114	CcSEcCtD
Zolmitriptan—Vomiting—Niacin—atherosclerosis	0.000786	0.00112	CcSEcCtD
Zolmitriptan—Rash—Niacin—atherosclerosis	0.00078	0.00111	CcSEcCtD
Zolmitriptan—Dermatitis—Niacin—atherosclerosis	0.000779	0.00111	CcSEcCtD
Zolmitriptan—Headache—Niacin—atherosclerosis	0.000775	0.0011	CcSEcCtD
Zolmitriptan—Vomiting—Pravastatin—atherosclerosis	0.000774	0.0011	CcSEcCtD
Zolmitriptan—Rash—Pravastatin—atherosclerosis	0.000768	0.00109	CcSEcCtD
Zolmitriptan—Dermatitis—Pravastatin—atherosclerosis	0.000767	0.00109	CcSEcCtD
Zolmitriptan—Headache—Pravastatin—atherosclerosis	0.000763	0.00109	CcSEcCtD
Zolmitriptan—Nausea—Niacin—atherosclerosis	0.000734	0.00105	CcSEcCtD
Zolmitriptan—Nausea—Pravastatin—atherosclerosis	0.000723	0.00103	CcSEcCtD
Zolmitriptan—HTR1D—connective tissue—atherosclerosis	0.000453	0.0653	CbGeAlD
Zolmitriptan—HTR1B—cardiovascular system—atherosclerosis	0.000407	0.0587	CbGeAlD
Zolmitriptan—HTR1D—cardiovascular system—atherosclerosis	0.000394	0.0568	CbGeAlD
Zolmitriptan—MAOA—connective tissue—atherosclerosis	0.000345	0.0498	CbGeAlD
Zolmitriptan—HTR1A—cardiovascular system—atherosclerosis	0.000328	0.0474	CbGeAlD
Zolmitriptan—MAOA—cardiovascular system—atherosclerosis	0.0003	0.0433	CbGeAlD
Zolmitriptan—MAOA—adipose tissue—atherosclerosis	0.000265	0.0382	CbGeAlD
Zolmitriptan—MAOA—liver—atherosclerosis	0.000186	0.0268	CbGeAlD
Zolmitriptan—CYP1A2—liver—atherosclerosis	0.000155	0.0223	CbGeAlD
Zolmitriptan—HTR1F—Signaling Pathways—APOA1—atherosclerosis	9.52e-05	0.000333	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL5—atherosclerosis	9.49e-05	0.000332	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CG—atherosclerosis	9.41e-05	0.000329	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CG—atherosclerosis	9.21e-05	0.000322	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ESR1—atherosclerosis	9.19e-05	0.000321	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	9.13e-05	0.000319	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—F2—atherosclerosis	9.08e-05	0.000318	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	9.02e-05	0.000315	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KNG1—atherosclerosis	8.98e-05	0.000314	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VWF—atherosclerosis	8.98e-05	0.000314	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGTR1—atherosclerosis	8.93e-05	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOC3—atherosclerosis	8.92e-05	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LDLR—atherosclerosis	8.87e-05	0.00031	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KNG1—atherosclerosis	8.8e-05	0.000308	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL2—atherosclerosis	8.76e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGTR1—atherosclerosis	8.74e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	8.74e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PLG—atherosclerosis	8.7e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CG—atherosclerosis	8.69e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL3—atherosclerosis	8.66e-05	0.000303	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL2—atherosclerosis	8.58e-05	0.0003	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PLG—atherosclerosis	8.52e-05	0.000298	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HMOX1—atherosclerosis	8.43e-05	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—MAPK3—atherosclerosis	8.32e-05	0.000291	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NCF1—atherosclerosis	8.3e-05	0.00029	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SOCS3—atherosclerosis	8.24e-05	0.000288	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—INS—atherosclerosis	8.23e-05	0.000288	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.14e-05	0.000285	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL2—atherosclerosis	8.09e-05	0.000283	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—F2—atherosclerosis	8.07e-05	0.000282	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOB—atherosclerosis	8.07e-05	0.000282	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SOCS3—atherosclerosis	8.07e-05	0.000282	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP3—atherosclerosis	7.96e-05	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1—atherosclerosis	7.96e-05	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AGT—atherosclerosis	7.93e-05	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF2—atherosclerosis	7.92e-05	0.000277	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTM1—atherosclerosis	7.85e-05	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	7.83e-05	0.000274	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR2—atherosclerosis	7.83e-05	0.000274	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CYBA—atherosclerosis	7.8e-05	0.000273	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP3—atherosclerosis	7.79e-05	0.000273	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF2—atherosclerosis	7.76e-05	0.000271	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCG1—atherosclerosis	7.74e-05	0.000271	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	7.73e-05	0.00027	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—LPL—atherosclerosis	7.71e-05	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOB—atherosclerosis	7.69e-05	0.000269	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLAT—atherosclerosis	7.63e-05	0.000267	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PARP1—atherosclerosis	7.63e-05	0.000267	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GHRL—atherosclerosis	7.63e-05	0.000267	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL8—atherosclerosis	7.63e-05	0.000267	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EDN1—atherosclerosis	7.57e-05	0.000265	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SERPINE1—atherosclerosis	7.56e-05	0.000264	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOB—atherosclerosis	7.53e-05	0.000263	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GPX1—atherosclerosis	7.52e-05	0.000263	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL5—atherosclerosis	7.51e-05	0.000263	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL8—atherosclerosis	7.47e-05	0.000261	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EDN1—atherosclerosis	7.41e-05	0.000259	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL5—atherosclerosis	7.36e-05	0.000257	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LPL—atherosclerosis	7.35e-05	0.000257	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—F2—atherosclerosis	7.33e-05	0.000256	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CD36—atherosclerosis	7.32e-05	0.000256	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—FABP4—atherosclerosis	7.28e-05	0.000254	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LCAT—atherosclerosis	7.28e-05	0.000254	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOS3—atherosclerosis	7.21e-05	0.000252	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LPL—atherosclerosis	7.19e-05	0.000252	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRKCG—atherosclerosis	7.14e-05	0.00025	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA4—atherosclerosis	7.14e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	7.02e-05	0.000245	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP7A1—atherosclerosis	7.02e-05	0.000245	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKCG—atherosclerosis	6.99e-05	0.000245	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SPP1—atherosclerosis	6.96e-05	0.000243	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—atherosclerosis	6.94e-05	0.000243	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL8—atherosclerosis	6.93e-05	0.000242	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SPP1—atherosclerosis	6.81e-05	0.000238	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARA—atherosclerosis	6.81e-05	0.000238	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL8—atherosclerosis	6.78e-05	0.000237	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KNG1—atherosclerosis	6.7e-05	0.000234	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.69e-05	0.000234	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	6.66e-05	0.000233	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AGT—atherosclerosis	6.59e-05	0.000231	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	6.53e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLG—atherosclerosis	6.49e-05	0.000227	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP27A1—atherosclerosis	6.48e-05	0.000227	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—atherosclerosis	6.46e-05	0.000226	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PDGFB—atherosclerosis	6.44e-05	0.000225	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CAV1—atherosclerosis	6.4e-05	0.000224	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—atherosclerosis	6.4e-05	0.000224	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOA1—atherosclerosis	6.39e-05	0.000223	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.38e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PDGFB—atherosclerosis	6.3e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGT—atherosclerosis	6.28e-05	0.00022	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.23e-05	0.000218	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—atherosclerosis	6.18e-05	0.000216	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—atherosclerosis	6.16e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—atherosclerosis	6.16e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGT—atherosclerosis	6.15e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	6.15e-05	0.000215	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA2—atherosclerosis	6.15e-05	0.000215	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	6.15e-05	0.000215	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALOX15—atherosclerosis	6.15e-05	0.000215	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	6.15e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CAV1—atherosclerosis	6.1e-05	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOA1—atherosclerosis	6.09e-05	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—atherosclerosis	6.08e-05	0.000213	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCG5—atherosclerosis	6.07e-05	0.000212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.07e-05	0.000212	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—atherosclerosis	6.03e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—atherosclerosis	6.03e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CAV1—atherosclerosis	5.97e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOA1—atherosclerosis	5.96e-05	0.000208	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP3—atherosclerosis	5.94e-05	0.000208	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF2—atherosclerosis	5.91e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ESR1—atherosclerosis	5.88e-05	0.000206	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPA—atherosclerosis	5.86e-05	0.000205	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—atherosclerosis	5.83e-05	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—F2—atherosclerosis	5.81e-05	0.000203	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—atherosclerosis	5.79e-05	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ESR1—atherosclerosis	5.76e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOB—atherosclerosis	5.74e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NFKB1—atherosclerosis	5.73e-05	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	5.69e-05	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—F2—atherosclerosis	5.69e-05	0.000199	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BGN—atherosclerosis	5.68e-05	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDN1—atherosclerosis	5.65e-05	0.000198	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.64e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK8—atherosclerosis	5.63e-05	0.000197	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—atherosclerosis	5.63e-05	0.000197	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA5—atherosclerosis	5.62e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—atherosclerosis	5.61e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL5—atherosclerosis	5.6e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—atherosclerosis	5.56e-05	0.000194	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—INS—atherosclerosis	5.52e-05	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LPL—atherosclerosis	5.48e-05	0.000192	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.46e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—atherosclerosis	5.44e-05	0.00019	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	5.41e-05	0.000189	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.35e-05	0.000187	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	5.33e-05	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK3—atherosclerosis	5.32e-05	0.000186	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.3e-05	0.000185	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.29e-05	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—INS—atherosclerosis	5.26e-05	0.000184	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.23e-05	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK3—atherosclerosis	5.21e-05	0.000182	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—atherosclerosis	5.2e-05	0.000182	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SPP1—atherosclerosis	5.19e-05	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL2—atherosclerosis	5.18e-05	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	5.17e-05	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—INS—atherosclerosis	5.15e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—atherosclerosis	5.15e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—atherosclerosis	5.09e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL2—atherosclerosis	5.07e-05	0.000177	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—atherosclerosis	5.06e-05	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—atherosclerosis	4.98e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK3—atherosclerosis	4.92e-05	0.000172	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—atherosclerosis	4.84e-05	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SERPINE1—atherosclerosis	4.83e-05	0.000169	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.83e-05	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	4.8e-05	0.000168	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—atherosclerosis	4.77e-05	0.000167	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SERPINE1—atherosclerosis	4.73e-05	0.000165	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.69e-05	0.000164	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGT—atherosclerosis	4.69e-05	0.000164	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.66e-05	0.000163	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LIPC—atherosclerosis	4.66e-05	0.000163	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOC3—atherosclerosis	4.63e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—atherosclerosis	4.61e-05	0.000161	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LDLR—atherosclerosis	4.6e-05	0.000161	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—atherosclerosis	4.59e-05	0.000161	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—atherosclerosis	4.59e-05	0.000161	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CAV1—atherosclerosis	4.55e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOA1—atherosclerosis	4.54e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—atherosclerosis	4.52e-05	0.000158	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CETP—atherosclerosis	4.49e-05	0.000157	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—atherosclerosis	4.43e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ESR1—atherosclerosis	4.38e-05	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—F2—atherosclerosis	4.33e-05	0.000151	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.3e-05	0.000151	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.19e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	4.14e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—atherosclerosis	4.09e-05	0.000143	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.06e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—atherosclerosis	4.01e-05	0.00014	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	3.97e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—atherosclerosis	3.95e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—INS—atherosclerosis	3.92e-05	0.000137	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—atherosclerosis	3.89e-05	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—atherosclerosis	3.87e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL2—atherosclerosis	3.86e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—atherosclerosis	3.81e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—atherosclerosis	3.8e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—atherosclerosis	3.7e-05	0.000129	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.67e-05	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKB1—atherosclerosis	3.66e-05	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—atherosclerosis	3.62e-05	0.000127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.62e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	3.6e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK8—atherosclerosis	3.6e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—atherosclerosis	3.59e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—atherosclerosis	3.59e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	3.59e-05	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	3.52e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	3.51e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—atherosclerosis	3.44e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—atherosclerosis	3.32e-05	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—atherosclerosis	3.32e-05	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—atherosclerosis	3.29e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	3.25e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—atherosclerosis	3.22e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK3—atherosclerosis	3.14e-05	0.00011	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.11e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	3.08e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	3.05e-05	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—atherosclerosis	3.05e-05	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	2.99e-05	0.000104	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOB—atherosclerosis	2.98e-05	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	2.95e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—atherosclerosis	2.9e-05	0.000102	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.9e-05	0.000101	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPL—atherosclerosis	2.84e-05	9.94e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX1—atherosclerosis	2.77e-05	9.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.76e-05	9.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.73e-05	9.55e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD36—atherosclerosis	2.7e-05	9.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.68e-05	9.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.68e-05	9.36e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.56e-05	8.95e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARA—atherosclerosis	2.51e-05	8.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.48e-05	8.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.45e-05	8.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AGT—atherosclerosis	2.43e-05	8.51e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—atherosclerosis	2.38e-05	8.33e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAV1—atherosclerosis	2.36e-05	8.26e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA1—atherosclerosis	2.36e-05	8.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.34e-05	8.2e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—atherosclerosis	2.3e-05	8.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.28e-05	7.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—atherosclerosis	2.25e-05	7.87e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—atherosclerosis	2.23e-05	7.78e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.15e-05	7.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—atherosclerosis	2.12e-05	7.42e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—atherosclerosis	2.08e-05	7.26e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—atherosclerosis	2.08e-05	7.26e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—INS—atherosclerosis	2.04e-05	7.12e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—atherosclerosis	1.87e-05	6.53e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—atherosclerosis	1.79e-05	6.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.71e-05	6e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.63e-05	5.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.58e-05	5.53e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—atherosclerosis	8.21e-06	2.87e-05	CbGpPWpGaD
